Medications for Kidney Transplantation

16 results

  • Azathioprine (azathioprine)

    (Azathioprine)
    Ascend Laboratories, LLC
    Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. Its combined use with other disease-modifying anti-rheumatic drugs has not been studied and is not recommended.

  • Azathioprine (azathioprine)

    (Azathioprine)
    Glenmark Pharmaceuticals, Inc
    Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal transplants and for managing active rheumatoid arthritis to reduce signs and symptoms. Its use with disease-modifying anti-rheumatic drugs has not been studied, and concurrent use is not recommended.

  • Cellcept

    (Mycophenolate Mofetil)
    Genentech, Inc.
    Usage: CELLCEPT (mycophenolate mofetil) is indicated for the prevention of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, used alongside other immunosuppressants.

  • Clotrimazole (clotrimazole)

    (clotrimazole)
    Physicians Total Care, Inc.
    Usage: Clotrimazole lozenges are indicated for the local treatment of oropharyngeal candidiasis and for prophylactic use to reduce incidence in immunocompromised patients undergoing chemotherapy, radiotherapy, or steroid therapy related to leukemia, solid tumors, or renal transplantation. Confirmation of diagnosis is required prior to treatment.

  • Cyclosporine (cyclosporine)

    (Cyclosporine)
    Strides Pharma Science Limited
    Usage: Cyclosporine capsules (modified) are indicated for the prophylaxis of organ rejection in kidney, liver, and heart transplants, treatment of severe rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who have not adequately responded to systemic therapies or cannot tolerate them.

  • Cyclosporine (cyclosporine)

    (Cyclosporine)
    Teva Pharmaceuticals USA, Inc.
    Usage: Cyclosporine capsules, USP MODIFIED are indicated for organ rejection prophylaxis in kidney, liver, and heart transplants, treatment of severe active rheumatoid arthritis unresponsive to methotrexate, and severe plaque psoriasis in adults who failed previous systemic therapies or cannot tolerate them.

  • Gengraf (cyclosporine)

    (Cyclosporine)
    AbbVie Inc.
    Usage: Gengraf® (cyclosporine oral solution, USP [MODIFIED]) is indicated for the prevention of organ rejection in kidney, liver, and heart transplants, as well as for treating severe active rheumatoid arthritis unresponsive to methotrexate and severe plaque psoriasis in adults who have failed prior systemic therapies.

  • Imuran (azathioprine)

    (azathioprine)
    Prometheus Laboratories Inc.
    Usage: IMURAN is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. It may be used alongside aspirin, NSAIDs, or low-dose glucocorticoids, but combined use with other DMARDs has not been studied.

  • Mycophenolate mofetil (mycophenolate mofetil)

    (Mycophenolate Mofetil)
    Camber Pharmaceuticals, Inc.
    Usage: Mycophenolate mofetil capsules are indicated for preventing organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressive agents.

  • Mycophenolate mofetil (mycophenolate mofetil)

    (MYCOPHENOLATE MOFETIL)
    Advagen Pharma Limited
    Usage: Mycophenolate mofetil (MMF) is indicated for the prophylaxis of organ rejection in adult and pediatric patients (3 months and older) receiving allogeneic kidney, heart, or liver transplants, in combination with other immunosuppressants.